Insider Transactions Reported by 13 Insiders of ACTUATE THERAPEUTICS, INC.

Symbol
ACTU on Nasdaq
Location
Fort Worth, TX

Insiders trading volume in the past year

ACTUATE THERAPEUTICS, INC. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Leslie W. Kreis Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
Bios Equity COF, LP Director, 10%+ Owner $111,175,297 +$499,996 +0.45% 27 Jun 2025
TODD S. THOMSON Director, 10%+ Owner $16,003,463 -$1,624,000 -9.2% 05 Jan 2026
DANIEL M. SCHMITT President, CEO and Director, Director $4,851,010 13 Feb 2026
Roger Sawhney Director 22 May 2025
AMY L. RONNEBERG Director 22 May 2025
Jason A. Keyes Director 22 May 2025
Andrew Paul Mazar Chief Operating Officer 01 Apr 2025
Bios 2024 Co-Invest, LP Director, Member of 10% Group 14 Aug 2024
Bios Clinical Opportunity Fund, LP 10%+ Owner 12 Aug 2024
PAUL J. LYTLE Chief Financial Officer 01 Apr 2025
Dan Zabrowski Director 22 May 2025

Recent Insider Transactions by Companies or Individuals for ACTUATE THERAPEUTICS, INC.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.